| abstract |
Macrocycle-inducing compounds that inhibit protein kinase enzymes are disclosed along with pharmaceutical compositions comprising these compounds and methods for synthesizing these compounds. Such compounds have use in the treatment of proliferative diseases resulting from unregulated and / or disturbed kinase activity such as cancer, psoriasis, viral and bacterial infections, inflammatory and autoimmune diseases. |